Биология ва тиббиёт муаммолари 2025, №4.1 (164)

Maqola mavzusi

РОЛЬ ДИЕТИЧЕСКИХ ВМЕШАТЕЛЬСТВ В ПРОФИЛАКТИКЕ НЕИНФЕКЦИОННЫХ ЗАБОЛЕВАНИЙ (18-23)

Mualliflar

Амлаев Карэн Робертович, Атоева Машхура Аброровна

Muassasa

Бухарский государственный медицинский институт, Республика Узбекистан, г. Бухара

Annotatsiya

Статья представляет собой краткий обзор опубликованной в базе данных PubMed в 2004-2024 годах релевантной научной литературы, отражающей роль и значение наиболее рекомендуемых для профилактики НИЗ диетических вмешательств. Дано описание ключевых особенностей средиземноморской диеты, диеты DASH и некоторых других. Приведены данные об их влиянии на уровень артериального давления, глюкозы крови, индекс массы тела. Отмечены барьеры для широкого использования данных диетических вмешательств, которые включают культурные особенности потребителей, более высокую стоимость предлагаемых диет, необходимость тратить больше времени на приготовление пищи, контролировать размер съедаемых порций.

Kalit so'zlar

диетические факторы, средиземноморская диета, японская диета, профилактика неинфекционных заболеваний.

Adabiyotlar

1. Abe C., Imai T., Sezaki A., et al. A longitudinal association between the traditional Japanese diet score and incidence and mortality of breast cancer — An ecological study. Eur. J. Clin. Nutr. 2021; 75:929–936. doi: 10.1038/s41430-020-00847-5. 2. AlAufi NS, Chan YM, Waly MI, et al. Applica-tion of Mediterranean Diet in Cardiovascular Diseases and Type 2 Diabetes Mellitus: Motivations and Challenges. Nutrients. 2022 Jul 5;14(13):2777. doi: 10.3390/nu14132777. PMID: 35807957; PMCID: PMC9268986. 3. Azadbakht L., Mirmiran P., Esmaillzadeh A., Azizi T., et al. Beneficial effects of a Dietary Ap-proaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care. 2005;28(12):2823–2831. doi: 10.2337/diacare.28.12.2823. 4. Bach-Faig A., Berry E.M., Lairon D., et al. Mediterranean diet pyramid today. Sci. Cult. Updates. Public Health Nutr. 2011; 14:2274–2284. doi: 10.1017/S1368980011002515. 5. Barnard N.D., Alwarith J., Rembert E., et al. A Mediterranean diet and low-fat vegan diet to improve body weight and cardiometabolic risk factors: a randomized, cross-over trial J. Am. Nutr. Assoc., 41 (2) (2022), pp. 127-139. 6. Bayes J., Schloss J., Sibbritt D. The effect of a Mediterranean diet on the symptoms of depression in young males (the “AMMEND” study): a randomized control trial Am. J. Clin. Nutr., 116 (2) (2022), pp. 572-580. 7. Bertoni A.G., Foy C.G., Hunter J.C., et al. A multilevel assessment of barriers to adoption of Dietary Approaches to Stop Hypertension (DASH) among African Americans of low socioeconomic status. J. Health Care Poor Underserved. 2011;22(4):1205–1220. doi: 10.1353/hpu.2011.0142. 8. Blumenthal J.A., Babyak M.A., Hinderliter A., et al. Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: The ENCORE study. Arch. Intern. Med. 2010;170(2):126–135. doi: 10.1001/archinternmed.2009.470. 9. Bonaccio M., Di Castelnuovo A., Costanzo S., et al. Association of a traditional Mediterranean diet and non-Mediterranean dietary scores with all-cause and cause-specific mortality: Prospective findings from the Moli-sani Study. Eur. J. Nutr. 2021; 60:729–746. doi: 10.1007/s00394-020-02272-7. 10. Bonsignore M.R. Obesity and obstructive sleep apnea Handb. Exp. Pharmacol., 274 (2022), pp. 181-20. 11. Boutari C., Mantzoros C.S. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on Metabolism, 133 (2022), Article 155217. 12. Bueno D.R., Marucci M.D., Gouveia L.A., et al. Abdominal obesi-ty and healthcare costs related to hypertension and diabetes in older adults. Rev. Nutr. 2017;30(2):209–218. doi: 10.1590/1678-98652017000200006. 13. Cao B., Xu J., Li R., et al. Interventions targeting comorbid depression and overweight/obesity: a systematic reviewJ. Affect. Disord., 314 (2022), pp. 222-232. 14. Carbone S., Billingsley H.E., Lavie C.J. The Effects of Dietary Sugars on Cardiovascular Disease and Cardiovascular Disease–Related Mortality: Finding the Sweet Spot. Mayo Clin. Proc. 2019; 94:2375–2377. doi: 10.1016/j.mayocp.2019.10.017. 15. Caristia S., De Vito M., Sarro A., et al. Is caloric restriction associated with better healthy aging outcomes? A systematic review and meta- analysis of randomized controlled trials. Nutrients. 2020; 12:2290. doi: 10.3390/nu12082290. 16. Ceriello A., Esposito K., La Sala L., et al. The protective effect of the Mediterranean diet on endothelial resistance to GLP-1 in type 2 diabetes: A preliminary report. Cardiovasc. Diabetol. 2014; 13:140. doi: 10.1186/s12933-014-0140-9. 17. Chen L., Magliano D.J., Zimmet P.Z. The worldwide epidemiology of type 2 diabetes mellitus–present and future perspectives Nat. Rev. Endocrinol., 8 (4) (2011), pp. 228-236. 18. Chiva-Blanch G., Badimon L., Estruch R. Latest evidence of the effects of the Mediterranean diet in prevention of cardiovascular disease. Curr. Atheroscler. Rep. 2014; 16:446. doi: 10.1007/s11883-014-0446-9. 19. Cowell O.R., Mistry N., Deighton K., et al. Effects of a Mediterranean diet on blood pressure: A systematic review and meta-analysis of randomized controlled trials and observational studies. J. Hypertens. 2021; 39:729–739. doi: 10.1097/HJH.0000000000002667. 20. Dinu M, Pagliai G, Casini A, Sofi F. Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials. Eur J Clin Nutr. 2018 Jan;72(1):30-43. doi: 10.1038/ejcn.2017.58. Epub 2017 May 10. PMID: 28488692. 21. Dominguez L.J., Bella G. Di, Veronese N., et al. Impact of Mediterranean diet on chronic non-communicable diseases and longevity Nutrients. 13 (6) (2021). 22. Dominguez L.J., Veronese N., Vernuccio L., Nutrition, physical activity, and other lifestyle factors in the prevention of cognitive decline and dementia Nutrients, 13 (11) (2021). 23. Doyle L., Cashman K.D. The DASH diet may have beneficial effects on bone health. Nutr. Rev. 2004;62(5):215–220. doi: 10.1301/nr.2004.may.215-220. 24. Effect of a nutritional and behavioral intervention on energy-reduced Mediterranean diet adherence among patients with metabolic syndrome: interim analysis of the PREDIMED-plus randomized clinical trial JAMA, 322 (15) (2019), pp. 1486-1499. 25. Elagizi A., Kachur S., Carbone S., et al. A review of obesity, physical activity, and cardiovascular disease Curr. Obes. Rep., 9 (4) (2020), pp. 571-58. 26. Eleftheriou D., Benetou V., Trichopoulou A., et al. Mediterranean diet and its components in relation to all-cause mortality: Meta-analysis. Br. J. Nutr. 2018; 120:1081–1097. doi: 10.1017/S0007114518002593. 27. Filippatos T.D., Panagiotakos D.B., Georgousopoulou E.N., et al. Mediterranean diet and 10-year (2002–2012) incidence of diabetes and cardiovascular disease in participants with prediabetes: The ATTICA study. Rev. Diabet. Stud. 2016; 13:226. doi: 10.1900/RDS.2016.13.226. 28. Firth J., Marx W., Dash S., et al. The Effects of Dietary Improvement on Symptoms of Depression and Anxiety: A Meta-Analysis of Randomized Controlled Trials. Psychosom. Med. 2019; 81:265. doi: 10.1097/PSY.0000000000000673. 29. García-Fernández E., Rico-Cabanas L., Rosgaard N., et al. Mediterranean diet and cardiodiabesity: A review. Nutrients. 2014; 6:3474–3500. 30. Gardner C.D., Landry M.J., Perelman D., et al. Effect of a ketogenic diet versus Mediterranean diet on glycated hemoglobin in individuals with prediabetes and type 2 diabetes mellitus: the interventional keto-med randomized crossover trial Am. J. Clin. Nutr., 116 (3) (2022), pp. 640-652. 31. Georgoulis M., Kontogianni M., Yiannakouris N. Mediterranean diet and diabetes: Prevention and treatment. Nutrients. 2014; 6:1406–1423. 32. Gomez-Huelgas R., Jansen-Chaparro S., Baca-Osorio A., et al. Effects of a long-term lifestyle intervention program with Mediterranean diet and exercise for the management of patients with metabolic syndrome in a primary care setting. Eur. J. Intern. Med. 2015; 26:317–323. 33. Haghighatdoost F., Sarrafzadegan N., Mohammadifard N., et al. Assessing body shape index as a risk predictor for cardiovascular diseases and metabolic syndrome among Iranian adults. Nutrition. 2014;30(6):636–644. 34. Jiang J., Liu M., Troy L.M., et al. Concordance with DASH diet and blood pressure change: Results from the Framingham Offspring Study (1991-2008). J. Hypertens. 2015;33(11):2223–2230. doi: 10.1097/HJH.0000000000000710. 35. Khan T.A., Tayyiba M., Agarwal A., et al. Relation of Total Sugars, Sucrose, Fructose, and Added Sugars with the Risk of Cardiovascular Disease: A Systematic Review and Dose-Response Meta-analysis of Prospective Cohort Studies. Mayo Clin. Proc. 2019; 94:2399–2414. doi: 10.1016/j.mayocp.2019.05.034 36. Kirkham A.A., Beka V., Prado C.M. The effect of caloric restriction on blood pressure and cardiovascular function: A systematic review and meta-analysis of randomized controlled trials. Clin. Nutr. 2021; 40:728–739. doi: 10.1016/j.clnu.2020.06.029. 37. Klonizakis M, Bugg A, Hunt B, et al. Assessing the Physiological Effects of Traditional Regional Diets Targeting the Prevention of Cardiovascular Disease: A Systematic Review of Randomized Controlled Trials Implementing Mediterranean, New Nordic, Japanese, Atlantic, Persian and Mexican Dietary Interventions. Nutrients. 2021 Aug 30;13(9):3034. doi: 10.3390/nu13093034. PMID: 34578911; PMCID: PMC8466163. 38. Kovesdy C.P., Furth S.L., Zoccali C. Obesity and kidney disease: hidden consequences of the epidemic Pediatr. Nephrol., 32 (4) (2017), pp. 537-545. 39. Kuang M., Lu S., Xie Q., et al. Abdominal obesity phenotypes are associated with the risk of developing non-alcoholic fatty liver disease: insights from the general population BMC Gastroenterol., 22 (1) (2022), p. 311. 40. Lauby-Secretan B., Scoccianti C., Loomis D., et al. Body fatness and cancer-viewpoint of the IARC working group N. Engl. J. Med., 375 (8) (2016), pp. 794-798. 41. Lin L., Bai S., Qin K., et al. Comorbid depression and obesity, and its transition on the risk of functional disability among middle-aged and older chinese: a cohort study BMC Geriatr., 22 (1) (2022), p. 275. 42. Lin P.H., Allen J.D., Li Y.J., et al. Blood pressure-lowering mechanisms of the DASH dietary pattern. J. Nutr. Metab. 2012;2012472396 43. Lindström J., Peltonen M., Eriksson J.G., et al. High-fibre, low-fat diet predicts long-term weight loss and decreased type 2 diabetes risk: the Finnish Diabetes Prevention Study. Diabetologia. 2006;49(5):912–920. 44. Mackenbach J.D., Burgoine T., Lakerveld J., et al. Accessibility and affordability of su-permarkets: associations with the DASH diet. Am. J. Prev. Med. 2017;53(1):55–62. 45. Martínez-González M.A., Gea A., Ruiz-Canela M. The Mediterranean diet and cardiovascular health: A critical review. Circ. Res. 2019; 124:779–798. 46. Morze J., Danielewicz A., Przybyłowicz K., et al. An updated systematic review and meta-analysis on adherence to Mediterranean diet and risk of cancer. Eur. J. Nutr. 2021; 60:1561–1586. 47. Nguyen T.V., Arisawa K., Katsuura-Kamano S., et al. Associations of metabolic syndrome and metabolically unhealthy obesity with cancer mortality: the Japan multi-institutional collaborative cohort (J-MICC) study PLoS One, 17 (7) (2022), Article e0269550. 48. Okada E., Nakamura K., Ukawa S., et al. The Japanese food score and risk of all-cause, CVD and cancer mortality: The Japan Collaborative Cohort Study. Br. J. Nutr. 2018; 120:464–471. 49. Papadaki A., Nolen-Doerr E., Mantzoros C.S. The effect of the mediterranean diet on metabolic health: A systematic review and meta-analysis of controlled trials in adults. Nutrients. 2020; 12:3342. 50. Purcell I., Hossain B., Evans G., et al. Morbid obesity and severe knee osteoarthritis: which should be treated First? J. Gastrointest. Surg., 26 (7) (2022), pp. 1388-1393. 51. Qin Z.-Z., Xu J.-Y., Chen G.-C., Ma Y.-X., Qin L.-Q. Effects of fatty and lean fish intake on stroke risk: A meta-analysis of prospective cohort studies. Lipids Health Dis. 2018; 17:1–7. 52. Quick Stats: prevalence of obesity* and severe obesity(dagger) among persons aged 2-19 years - National Health and Nutrition Examination Survey, 1999-2000 through 2017-2018 MMWR Morb. Mortal. Wkly Rep., 69 (13) (2020), p. 390. 53. Rai S.K., Fung T.T., Lu N., et al. The Dietary Ap-proaches to Stop Hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study. BMJ. 2017;357: j1794. 54. Reynolds A., Mann J., Cummings J., et al. Carbohydrate quality and human health: A series of systematic reviews and meta-analyses. Lancet. 2019; 393:434–445. 55. Salehi-Abargouei A., Maghsoudi Z., Shirani F., et al. Effects of Dietary Ap-proaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases--incidence: A systematic review and meta-analysis on observational prospective studies. Nutrition. 2013;29(4):611–618. doi: 10.1016/j.nut.2012.12.018. 56. Satokari R. High Intake of Sugar and the Balance between Pro- and Anti-Inflammatory Gut Bacteria. Nutrients. 2020; 12:1348. doi: 10.3390/nu12051348. 57. Shen J., Wilmot K.A., Ghasemzadeh N., et al. Mediterranean dietary patterns and cardiovascular health. Annu. Rev. Nutr. 2015; 35:425–449. 58. Suri S, Kumar V, Kumar S, Goyal A, Tanwar B, Kaur J, Kaur J. DASH Dietary Pattern: A Treatment for Non-Communicable Diseases. Curr Hypertens Rev. 2020;16(2):108-114. 59. Taylor E.N., Fung T.T., Curhan G.C. DASH-style diet associates with reduced risk for kidney stones. J. Am. Soc. Nephrol. 2009;20(10):2253–2259. 60. Te Morenga L., Mallard S., Mann J. Dietary sugars and body weight: Systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ. 2013;346: e7492. doi: 10.1136/bmj. e7492. 61. The Mediterranean lifestyle and the risk of depression in middle-aged adults J. Nutr., 152 (1) (2022), pp. 227-234; 62. Tong T.Y., Imamura F., Monsivais P., at al. Dietary cost associated with adherence to the Mediterranean diet, and its variation by socio-economic factors in the UK Fenland Study. Br. J. Nutr. 2018; 119:685–694. 63. Tsigalou C., Konstantinidis T., Paraschaki A., et al. Mediterranean Diet as a Tool to Combat Inflammation and Chronic Diseases. An Overview. Biomedicines. 2020; 8:201. 64. Tsigalou C., Paraschaki A., Karvelas A., et al. Gut microbiome and Mediterranean diet in the context of obesity. Current knowledge, perspectives and potential therapeutic targets. Metab. Open. 2021; 9:100081. 65. Vamvakis A., Gkaliagkousi E., Lazaridis A., et al. Impact of intensive lifestyle treatment (Diet plus exercise) on endothelial and vascular function, arterial stiffness and blood pressure in stage 1 hypertension: Results of the HINTreat randomized controlled trial. Nutrients. 2020; 12:1326. 66. WHO; . WHO; Geneva, Switzerland: 2018. 67. Willett W., Rockstrom J., Loken B., et al. Food in the anthropocene: the EAT-lancet commission on healthy diets from sustainable food systems Lancet, 393 (10170) (2019), pp. 447-492. 68. Zhang B., Xiong K., Cai J., et al. Fish Consumption and Coronary Heart Disease: A Meta-Analysis. Nutrients. 2020; 12:2278.